SANTA ANA, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO) today announced that its registration statement on Form S-3 relating to resales by security holders of the company’s issued and outstanding 1.375% Convertible Senior Subordinated Notes due 2025, and the shares of its common stock issuable upon conversion of the Notes, was declared effective by the Securities and Exchange Commission. A copy of the prospectus may be obtained from Investor Relations, Advanced Medical Optics, Inc., 1700 St. Andrew Place, Santa Ana, CA 92705.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO )
The registration statement was filed on behalf of the selling security holders, and AMO will not receive any proceeds from the resale of the Notes or the underlying common stock.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any State in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such State.
About Advanced Medical Optics (AMO)
AMO is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO owns or has the rights to such ophthalmic surgical product brands as ReZoom(TM), Clariflex(R), Sensar(R), Tecnis(R) and Verisyse(TM) intraocular lenses, STAR S4 IR(TM) laser vision correction system, WaveScan Wavefront(R) System, CustomVue(TM) procedure, Sovereign(R) and Sovereign(R) Compact TM phacoemulsification systems with WhiteStar(TM) technology, Amadeus(TM) II microkeratomes, Healon(R) viscoelastics, and the Baerveldt(R) glaucoma shunt. Products in the contact lens care line include disinfecting solutions, daily cleaners, enzymatic cleaners and lens rewetting drops. Among the contact lens care product brands the company promotes are COMPLETE(R) Moisture PLUS(TM), COMPLETE(R) Blink-N-Clean(R), Consept(R) 1 Step, Oxysept(R) 1 Step, and blink(TM). Amadeus is a licensed product of, and a trademark of, SIS, Ltd. AMO is based in Santa Ana, California, and employs approximately 3,500 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries. For more information, visit the company’s Web site at www.amo-inc.com.
Investor Contact: Sheree Aronson (714) 247-8290 sheree.aronson@amo-inc.com Media Contact: Steve Chesterman (714) 247-8711 steve.chesterman@amo-inc.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comAdvanced Medical Optics, Inc.
CONTACT: Investors, Sheree Aronson, +1-714-247-8290,sheree.aronson@amo-inc.com, or Media, Steve Chesterman, +1-714-247-8711,steve.chesterman@amo-inc.com, both of Advanced Medical Optics, Inc.
Web site: http://www.amo-inc.com/
